Terms: = Lymphoma AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Treatment
471 results:
1. Follicular lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases.
Sarro R; Bisig B; Guey B; Missiaglia E; Cairoli A; Omoumi P; Letovanec I; Ferry JA; Hasserjian RP; de Leval L
Mod Pathol; 2024 Apr; 37(4):100440. PubMed ID: 38290600
[TBL] [Abstract] [Full Text] [Related]
2. MYC rearrangements in HIV-associated large B-cell lymphomas: EUROMYC, a European retrospective study.
Pagani C; Rusconi C; Dalla Pria A; Ravano E; Schommers P; Bastos-Oreiro M; Verga L; Gini G; Spina M; Arcaini L; Steffanoni S; Dalu D; Crucitti L; Lorenzi L; Balzarini P; Cattaneo C; Bongiovanni L; Rosenwald A; Facchetti F; Bower M; Ferreri AJM; Rossi G; Tucci A; Re A
Blood Adv; 2024 Feb; 8(4):968-977. PubMed ID: 38207206
[TBL] [Abstract] [Full Text] [Related]
3. [Clinical study of mature B-cell lymphoma in 11 children with chromosome 11 long-arm abnormalities].
Zhang N; Duan YL; Zhou CJ; Jin L; Yang J; Huang S; Zhang M; Li N
Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):924-929. PubMed ID: 38185522
[No Abstract] [Full Text] [Related]
4. A rare case of fluid overload-associated large B-cell lymphoma and antigen loss at relapse.
Yan X; Chen B; Jing H; Yang Z; Zhang T; Lin Y; Shi J
J Hematop; 2023 Dec; 16(4):235-240. PubMed ID: 38175437
[TBL] [Abstract] [Full Text] [Related]
5. Selectively targeting bcl6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer.
Wu M; Xie J; Xing Y; Zhang L; Chen H; Tang B; Zhou M; Lv S; Huang D; Jian S; Zhou C; Liu M; Guo W; Chen Y; Yi Z
Int J Biol Sci; 2024; 20(2):486-501. PubMed ID: 38169532
[TBL] [Abstract] [Full Text] [Related]
6. [Analysis of 9 cases of pediatric-type follicular lymphoma].
Li GP; Zhang D; Wang YQ; Li ZY; Yuan FF; Li MH; Wang L; Du JW; Zhang LN; Li YF; Wei XD; Fu YW
Zhonghua Er Ke Za Zhi; 2023 Dec; 61(12):1129-1132. PubMed ID: 38018051
[No Abstract] [Full Text] [Related]
7. [Clinical pathological characteristics analysis of ocular adnexal follicular lymphoma].
Li J; Wang YC; Lin JY
Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):930-936. PubMed ID: 37936361
[No Abstract] [Full Text] [Related]
8. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.
Huang F; Ruan Y; He X; Lian H; Yang J
World J Surg Oncol; 2023 Oct; 21(1):342. PubMed ID: 37884941
[TBL] [Abstract] [Full Text] [Related]
9. miR-6076 targets bcl6 in SH-SY5Y cells to regulate amyloid-β-induced neuronal damage.
Lin Y; Zhang L; Gao M; Tang Z; Cheng X; Li H; Qin J; Tian M; Jin G; Zhang X; Li W
J Cell Mol Med; 2023 Dec; 27(24):4145-4154. PubMed ID: 37849385
[TBL] [Abstract] [Full Text] [Related]
10. Primary rectal mucosa-associated lymphoid tissue lymphoma masquerading as proctitis.
Zhang JY; Fu BZ; Yin ZK; Li J
Rev Esp Enferm Dig; 2023 Dec; 115(12):744-745. PubMed ID: 37706448
[TBL] [Abstract] [Full Text] [Related]
11. Consolidative Autotransplantation Achieves High Cure Rates in Adverse-Risk Large B Cell lymphoma.
Puckrin R; Sterrett R; Chua N; Owen C; Duggan P; Shafey M; Stewart D
Transplant Cell Ther; 2023 Dec; 29(12):763.e1-763.e5. PubMed ID: 37703996
[TBL] [Abstract] [Full Text] [Related]
12. [Nodal T-follicular helper cell lymphoma, angioimmunoblastic-type associated with diffuse large B-cell lymphoma: a clinicopathological study].
Wang GN; Zhao WG; Zhang DD; Zhang YP; Liu EJ; Lu SS; Li WC
Zhonghua Bing Li Xue Za Zhi; 2023 Sep; 52(9):918-923. PubMed ID: 37670621
[No Abstract] [Full Text] [Related]
13. The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas.
Salaverria I; Weigert O; Quintanilla-Martinez L
Blood Adv; 2023 Sep; 7(18):5258-5271. PubMed ID: 37561599
[TBL] [Abstract] [Full Text] [Related]
14. CDK9 INHIBITORS: a promising combination partner in the treatment of hematological malignancies.
Morillo D; Vega G; Moreno V
Oncotarget; 2023 Aug; 14():749-752. PubMed ID: 37552223
[TBL] [Abstract] [Full Text] [Related]
15. Molecularly Stratified treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or bcl6 Rearrangements (HGBL, NOS with MYC/bcl6).
Witte HM; Riedl J; Künstner A; Fähnrich A; Ketzer J; Fliedner SMJ; Reimer N; Bernard V; von Bubnoff N; Merz H; Busch H; Feller A; Gebauer N
Target Oncol; 2023 Sep; 18(5):749-765. PubMed ID: 37488307
[TBL] [Abstract] [Full Text] [Related]
16. HBV-associated DLBCL of poor prognosis: advance in pathogenesis, immunity and therapy.
Wan X; Young KH; Bai O
Front Immunol; 2023; 14():1216610. PubMed ID: 37483605
[TBL] [Abstract] [Full Text] [Related]
17. Long-term outcomes in patients with Burkitt lymphoma older than 65 years: an analysis of the Texas Cancer Registry.
Burns EA; Wilson JJ; Mathur S; Kieser R; Gong Z; Hu CA; Tang CA; Petkova J; Yuen C; Mai H; Shah S; Rice L; Ganguly S; Pingali SR
Ann Hematol; 2023 Oct; 102(10):2753-2763. PubMed ID: 37422592
[TBL] [Abstract] [Full Text] [Related]
18. Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
Correia C; Maurer MJ; McDonough SJ; Schneider PA; Ross PE; Novak AJ; Feldman AL; Cerhan JR; Slager SL; Witzig TE; Eckloff BW; Li H; Nowakowski GS; Kaufmann SH
Blood Cancer J; 2023 May; 13(1):81. PubMed ID: 37193683
[TBL] [Abstract] [Full Text] [Related]
19. Diffuse large B-cell lymphoma research in Malaysia: A review.
Lim KG; Sumera A; Burud IAS; Venkateswaran SP
Malays J Pathol; 2023 Apr; 45(1):1-10. PubMed ID: 37119241
[TBL] [Abstract] [Full Text] [Related]
20. MYD88
Qin Y; Qiu T; Xie Z; Chen X; Liu P; Yang J; He X; Gui L; Zhou S; Jiang H; Zhang C; Yang S; Tang L; Shi Y
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8483-8494. PubMed ID: 37093346
[TBL] [Abstract] [Full Text] [Related]
[Next]
